Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.
about
Histone demethylases and cancer.SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer.SET and MYND domain containing protein 3 in cancer.SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3.SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production.Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significance.Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers.Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells.Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.[Advances of histone methyltransferase SMYD3 in tumors].
P2860
Q36421138-29931CC4-66C6-4E2E-9889-5EBA0AD34829Q37551171-45D268D1-AF48-45DF-B20B-49C7E8B6824EQ37596853-75AB3E03-585D-41A1-9DCA-E7703391FCCFQ38874203-176E70AA-0757-4D8D-85DA-BBBDF73C4CE2Q38932430-07739DD8-B6AE-4D10-87BA-B423FD84DC7EQ38968729-CFD00AB5-0191-4326-B6CE-CD4C5D1AA277Q39055609-9A29FE29-1250-4A90-9165-023B0B0CF3CAQ39842797-A67CFC69-F7FF-4C58-89B0-52B7798E1B80Q40257588-1305752E-11AD-4162-ABF2-0F4F07C1D370Q40387247-C0FF6871-AD13-4901-8D40-1374FC262715Q45387956-4BA7B64E-875E-443E-A9A1-83F8F5759D8DQ53634111-47F20FA7-25D3-43E3-B88A-137D17764643Q53677558-831C41C5-4FF7-4829-83C5-698CE4F18A31Q55129685-DB96B2D9-27E4-4B3F-A6D1-87CD1A2A949FQ55504750-F2B0C89A-458A-4F1A-84BD-A44F8EFAEAF3
P2860
Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@ast
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@en
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@nl
type
label
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@ast
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@en
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@nl
prefLabel
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@ast
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@en
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@nl
P2093
P2860
P356
P1476
Silencing SMYD3 in hepatoma de ...... l proliferation and migration.
@en
P2093
Guo-Bin Wang
Jun-Yao Xu
Li-Bo Chen
P2860
P304
P356
10.3748/WJG.V13.I43.5718
P407
P577
2007-11-01T00:00:00Z